LOGIN
NSAID significantly reduces incidence of heterotopic ossification after hip arthroscopy
April 2016
NSAID significantly reduces incidence of heterotopic ossification after hip arthroscopy
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized Placebo-Controlled Trial
J Bone Joint Surg Am. 2015 Dec 16;97(24):2032-7Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
108 patients scheduled for hip arthroscopy due to femoroacetabular impingement were randomized to receive either naproxen 500mg or placebo twice daily for the first 3 weeks postoperatively. The purpose of this study was to evaluate if non-steroidal anti-inflammatory drug (NSAID) prophylaxis with naproxen significantly reduced the incidence of heterotopic ossification over 1-year follow-up. Planned...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.